The use of herbs to prevent (primarily) and treat some major men's health concerns are reviewed. For benign prostatic hyperplasia, the roles of Serenoa repens (saw palmetto), Prunus africanum (pygeum), Urtica dioica (nettle) root, and Ammi visnaga (khella) are discussed. For prostate cancer, Punica granatum (pomegranate), Allium sativum (garlic), and Glycine max (soy) and other legumes—including their isoflavones—are reviewed. For two conditions related to obesity and metabolic syndrome, erectile dysfunction and secondary hypogonadism, the roles of pomegranate, Epimedium spp. (horny goat weed), Panax ginseng (Asian ginseng), Crocus sativa (saffron), and phytoestrogens are discussed.
Get full access to this article
View all access options for this article.
References
1.
GuFL, XiaTL, KongXT. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China. Urology, 1994; 44:688–691.
2.
GuF. Changes in the prevalence of benign prostatic hyperplasia in China. Chin Med J (Engl), 1997; 110:163–166.
3.
GuF. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China. Chin Med J (Engl), 2000; 113:299–302.
4.
TacklindJ, MacdonaldR, RutksI, et al.Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev, 2012; 12:CD001423.
5.
CarraroJC, RaynaudJP, KochG, et al.Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients. Prostate, 1996; 29:231–240;discussion:241–242.
6.
Di SilverioF, D'EramoG, FlammiaGP, et al.Pharmacological combinations in the treatment of benign prostatic hypertrophy [in French]. J Urol (Paris), 1993; 99:316–320.
7.
DjavanB, FongYK, ChaudryA, et al.Progression delay in men with mild symptoms of bladder outlet obstruction: A comparative study of phytotherapy and watchful waiting. World J Urol, 2005; 23:253–256.
8.
AliaevIuG, VinarovAZ, DemidkoIuL, SpivakLG. The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia [in Russian]. Urologiia, 2013; 4:32–36.
9.
CunninghamAB, MbenkumFT. Sustainability of Harvesting Prunus africana Bark in Cameroon: A Medicinal Plant in International Trade. People and Plants Working Paper No. 2. Paris: UNESCO, 1993. Online document at: http://unesdoc.unesco.org/images/0009/000987/098761E.pdf Accessed April6, 2016.
10.
FischerM, WilbertD. Test of a phytomedicine for treatment of benign prostatic hyperplasia (BPH). In: Benign Prostatic Hyperplasia III: Clinical and Experimental Urology [in German], vol. 22. New York: W Zuckswerdt, 1992:79–84.
LopatkinN, SivkovA, WaltherC, et al.Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms—a placebo-controlled, double-blind, multicenter trial. World J Urol, 2005; 23:139–146.
13.
SökelandJ, AlbrechtJ. Combination of sabal and urtica extract vs. finasteride in benign prostatic hyperplasia (Aiken stages I to II): Comparison of therapeutic effectiveness in a one year double-blind study [in German]. Urologe A, 1997; 36:327–333.
14.
YarnellE, AbascalK. Spasmolytic botanicals: Relaxing smooth muscles with herbs. Altern Complement Ther, 2011; 17:169–174.
15.
YarnellE. Natural Approach to Urology and Men's Health, 2nd ed. Wenatchee, WA: Wild Brilliance Press, 2016 [in press].
16.
ChouR, CroswellJM, DanaT, et al.Screening for prostate cancer: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med, 2011; 155:762–771.
17.
FreedlandSJ, CarducciM, KroegerN, et al.A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy. Cancer Prev Res (Phila), 2013; 6:1120–1127.
18.
WangL, AlconA, YuanH, et al.Cellular and molecular mechanisms of pomegranate juice–induced anti-metastatic effect on prostate cancer cells. Integr Biol (Camb), 2011; 3:742–754.
19.
PallerCJ, YeX, WozniakPJ, et al.A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate Cancer Prostatic Dis, 2013; 16:50–55.
20.
WangL, Martins-GreenM. Pomegranate and its components as alternative treatment for prostate cancer. Int J Mol Sci, 2014; 15:14949–14966.
21.
ThomasR, WilliamsM, SharmaH, et al.A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the U.K. NCRN Pomi-T study. Prostate Cancer Prostatic Dis, 2014; 17:180–186.
22.
ZhouXF, DingZS, LiuNB. Allium vegetables and risk of prostate cancer: Evidence from 132,192 subjects. Asian Pac J Cancer Prev, 2013; 14:4131–4134.
23.
BraskyTM, KristalAR, NavarroSL, et al.Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort. Nutr Cancer, 2011; 63:573–582.
24.
DurakI, YılmazE, DevrimE, et al.Consumption of aqueous garlic extract leads to significant improvement in patients with benign prostate hyperplasia and prostate cancer. Nutr Res, 2003; 23:199–204.
25.
MahmoudAM, YangW, BoslandMC. Soy isoflavones and prostate cancer: A review of molecular mechanisms. J Steroid Biochem Mol Biol, 2014; 140:116–132.
26.
McCormickDL, JohnsonWD, BoslandMC, et al.Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor. Nutr Cancer, 2007; 57:184–193.
27.
van DieMD, BoneKM, WilliamsSG, PirottaMV. Soy and soy isoflavones in prostate cancer: A systematic review and meta-analysis of randomized controlled trials. BJU Int, 2014; 113(5b):E119–E130.
28.
HwangYW, KimSY, JeeSH, et al.Soy food consumption and risk of prostate cancer: A meta-analysis of observational studies. Nutr Cancer, 2009; 61:598–606.
29.
YanL, SpitznagelEL. Soy consumption and prostate cancer risk in men: A revisit of a meta-analysis. Am J Clin Nutr, 2009; 89:1155–1163.
30.
SetchellKD, BrownNM, Lydeking-OlsenE. The clinical importance of the metabolite equol—a clue to the effectiveness of soy and its isoflavones. J Nutr, 2002; 132:3577–3584.
31.
SetchellKD, ClericiC, LephartED, et al.S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr, 2005; 81:1072–1079.
32.
MatthiesA, LohG, BlautM, BrauneA. Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J Nutr, 2012; 142:40–46.
33.
SongKB, AtkinsonC, FrankenfeldCL, et al.Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr, 2006; 136:1347–1351.
34.
MaskarinecG, YamakawaR, HebshiS, FrankeAA. Urinary isoflavonoid excretion and soy consumption in three generations of Japanese women in Hawaii. Eur J Clin Nutr, 2007; 61:255–261.
35.
FrankenfeldCL. Dairy consumption is a significant correlate of urinary equol concentration in a representative sample of US adults. Am J Clin Nutr, 2011; 93:1109–1116.
36.
HalmBM, FrankeAA, AshburnLA, et al.Oral antibiotics decrease urinary isoflavonoid excretion in children after soy consumption. Nutr Cancer, 2008; 60:14–22.
37.
HamurH, DumanH, KeskinE, et al.The relation between erectile dysfunction and extent of coronary artery disease in the patients with stable coronary artery disease. Int J Clin Exp Med, 2015; 8:21295–21302.
38.
CastelaÂ, CostaC. Molecular mechanisms associated with diabetic endothelial-erectile dysfunction. Nat Rev Urol, 2016; February16:e-pub ahead of print.
39.
YarnellE. Herbs for erectile dysfunction. Altern Complement Ther, 2015; 21:276–283.
40.
ForestCP, Padma-NathanH, LikerHR. Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: A randomized, placebo-controlled, double-blind, crossover study. Int J Impot Res, 2007; 19:564–567.
41.
PunyawudhoB, PuttilerpongC, WirotsaengthongS, AramwitP. A randomized, double-blind, placebo-controlled crossover study of Cappra® for the treatment of mild or mild to moderate erectile dysfunction in Thai male [sic]. Afr J Tradit Complement Altern Med, 2012; 10:310–315.
42.
NishimatsuH, KitamuraT, YamadaD, et al.Improvement of symptoms of aging in males by a preparation LEOPIN ROYAL containing aged garlic extract and other five of [sic] natural medicines—comparison with traditional herbal medicines (Kampo). Aging Male, 2014; 17:112–116.
43.
HausenblasHA, SahaD, DubyakPJ, AntonSD. Saffron (Crocus sativus L) and major depressive disorder: A meta-analysis of randomized clinical trials. J Integr Med, 2013; 11:377–383.
44.
ShamsaA, HosseinzadehH, MolaeiM, et al.Evaluation of Crocus sativus L (saffron) on male erectile dysfunction: A pilot study. Phytomedicine, 2009; 16:690–693.
45.
ModabberniaA, SohrabiH, NasehiAA, et al.Effect of saffron on fluoxetine-induced sexual impairment in men: Randomized double-blind placebo-controlled trial. Psychopharmacology (Berl), 2012; 223:381–388.
46.
JangDJ, LeeMS, ShinBC, et al.Red ginseng for treating erectile dysfunction: A systematic review. Br J Clin Pharmacol, 2008; 66:444–450.
47.
ChoiJ, KimTH, ChoiTY, LeeMS. Ginseng for health care: A systematic review of randomized controlled trials in Korean literature. PLoS One, 2013; 8:e59978.
48.
ChoiYD, ParkCW, JangJ, et al.Effects of Korean ginseng berry extract on sexual function in men with erectile dysfunction: A multicenter, placebo-controlled, double-blind clinical study. Int J Impot Res, 2013; 25:45–50.
49.
TajarA, FortiG, O'NeillTW, et al.Characteristics of secondary, primary, and compensated hypogonadism in aging men: Evidence from the European Male Ageing Study. J Clin Endocrinol Metab, 2010; 95:1810–1818.
50.
Ioannidou-KadisS, WrightPJ, NeelyRD, QuintonR. Complete reversal of adult-onset isolated hypogonadotropic hypogonadism with clomiphene citrate. Fertil Steril, 2006; 86:1513.e5–e9.
51.
ArispeSA, AdamsB, AdamsTE. Effect of phytoestrogens on basal and GnRH-induced gonadotropin secretion. J Endocrinol, 2013; 219:243–250.
52.
LoutchanwootP, SrivilaiP, JarryH. Effects of the natural endocrine disruptor equol on the pituitary function in adult male rats. Toxicology, 2013; 304:69–75.
53.
AllenNE, ApplebyPN, DaveyGK, KeyTJ. Soy milk intake in relation to serum sex hormone levels in British men. Nutr Cancer, 2001; 41:41–46.
